Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study.
about
Pharmacological interventions for challenging behaviour in children with intellectual disabilities: a systematic review and meta-analysis.Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options.Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidoneEarly-life risperidone administration alters maternal-offspring interactions and juvenile play fightingPredictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectrum disorder: a meta-analysisAn open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder.What's in the pipeline? Drugs in development for autism spectrum disorder.Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder.Effects of risperidone on core symptoms of autistic disorder based on childhood autism rating scale: an open label study.The effect of antidepressants and antipsychotics on weight gain in children and adolescents.Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials.Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology.What Have Proteomic Studies Taught Us About Novel Drug Targets in Autism?Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents.
P2860
Q26776479-FF9B7F3C-D2D0-4DB0-B48F-5F81D4892670Q28394524-6312540C-1FA3-45E5-BBBA-21C2824ECC3EQ30235878-3329B1A4-AACD-47B2-BEBB-5A79937F8373Q35024279-73A778DE-6261-4142-A6A9-E0886641863AQ35170686-CD7E1F20-0292-4EF6-857A-517B8CC499A5Q37347743-5072C202-2C28-4194-9209-D75616BE294FQ37409074-2CC45080-9F80-47C3-AB16-1D70924B1EB6Q38193069-601FDC99-D6A5-49DD-9AC5-CC116CDDEC61Q38266796-88DDDDA8-5F77-47BF-ADE4-08E5D2263EDBQ38348189-3C9B8D6B-E989-4D7D-9D41-74EB69AC1CEFQ38504263-07295187-4D39-477B-9A64-76DA1793A01DQ42373848-9E873ABB-9192-41BE-9703-BF5BEA3D02BDQ46111793-63F62984-D9C4-4832-8A1B-2556F46BD8F2Q47812079-CA36E88D-60DB-481D-9FC8-803B03F903D4Q49332454-F9E144F4-F6D0-42F6-A636-43FCC5EED800
P2860
Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Risperidone dosing in children ...... ind, placebo-controlled study.
@en
Risperidone dosing in children ...... ind, placebo-controlled study.
@nl
type
label
Risperidone dosing in children ...... ind, placebo-controlled study.
@en
Risperidone dosing in children ...... ind, placebo-controlled study.
@nl
prefLabel
Risperidone dosing in children ...... ind, placebo-controlled study.
@en
Risperidone dosing in children ...... ind, placebo-controlled study.
@nl
P2093
P2860
P921
P1476
Risperidone dosing in children ...... ind, placebo-controlled study.
@en
P2093
David Hough
Jaskaran Singh
Justine M Kent
Keith Karcher
Michael Aman
Stuart Kushner
Xiaoping Ning
P2860
P2888
P304
P356
10.1007/S10803-012-1723-5
P407
P577
2013-08-01T00:00:00Z